秘鲁人食用药用植物预防 COVID-19 的相关因素:一项横断面研究。

Q3 Medicine
Fabricio Ccami-Bernal, Cristhian Rojas-Miliano, David R Soriano-Moreno, Daniel Fernández-Guzmán, Carlos Quispe-Vicuña, Enrique A Hernández-Bustamante, Elvira G Zamora-Huaringa, Wendy Nieto-Gutiérrez
{"title":"秘鲁人食用药用植物预防 COVID-19 的相关因素:一项横断面研究。","authors":"Fabricio Ccami-Bernal, Cristhian Rojas-Miliano, David R Soriano-Moreno, Daniel Fernández-Guzmán, Carlos Quispe-Vicuña, Enrique A Hernández-Bustamante, Elvira G Zamora-Huaringa, Wendy Nieto-Gutiérrez","doi":"10.17843/rpmesp.2024.411.13265","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives.: </strong>Motivation for the study. No study conclusively recommends the use of medicinal plants to treat COVID-19 symptoms, and their indiscriminate use may present health risks. Main findings. Sixty percent of participants consumed medicinal plants to prevent COVID-19. This was particularly true for those living in the Peruvian highlands and individuals with family members diagnosed or deceased from COVID-19, who perceive a higher risk of infection and use medications or chlorine dioxide as preventive measures. Implications. Communication strategies emphasizing validated preventive practices and educating about the risks of consuming medicinal plants should be tailored to the predominant characteristics of the consumer. Determine the factors associated with the consumption of medicinal plants as a preventive measure against COVID-19 in the Peruvian population.</p><p><strong>Materials and methods.: </strong>A population over 18 years of age, living in Peru and without a history of COVID-19 disease, was evaluated. The factors associated with the consumption of medicinal plants were evaluated using a Poisson regression model with robust variances.</p><p><strong>Results.: </strong>Of the 3231 participants included, 84.6% were young adults (18-29 years old), 62.7% were women, and 59.7% consumed a medicinal plant to prevent COVID-19 infection. The factors associated with the consumption of medicinal plants to prevent COVID-19 infection were residing in the Peruvian highlands, having had a family member diagnosed with COVID-19, having had a family member die from COVID-19, considering their family to be at increased risk of infection, having used medications or chlorine dioxide to prevent COVID-19, having medical information as the main source of information about COVID-19, thinking that medicinal plants are effective in preventing COVID-19 disease, or not being informed about their effectiveness.</p><p><strong>Conclusion.: </strong>Sixty percent of the participants reported having consumed a medicinal plant to prevent COVID-19. Authorities must apply communication strategies about the implications of consuming medicinal plants, prioritizing population groups with higher consumption patterns.</p>","PeriodicalId":53651,"journal":{"name":"Revista Peruana de Medicina de Experimental y Salud Publica","volume":"41 1","pages":"37-45"},"PeriodicalIF":0.0000,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11149759/pdf/","citationCount":"0","resultStr":"{\"title\":\"Factors associated with the consumption of medicinal plants for the prevention of COVID-19 in peruvian population: a cross-sectional study.\",\"authors\":\"Fabricio Ccami-Bernal, Cristhian Rojas-Miliano, David R Soriano-Moreno, Daniel Fernández-Guzmán, Carlos Quispe-Vicuña, Enrique A Hernández-Bustamante, Elvira G Zamora-Huaringa, Wendy Nieto-Gutiérrez\",\"doi\":\"10.17843/rpmesp.2024.411.13265\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives.: </strong>Motivation for the study. No study conclusively recommends the use of medicinal plants to treat COVID-19 symptoms, and their indiscriminate use may present health risks. Main findings. Sixty percent of participants consumed medicinal plants to prevent COVID-19. This was particularly true for those living in the Peruvian highlands and individuals with family members diagnosed or deceased from COVID-19, who perceive a higher risk of infection and use medications or chlorine dioxide as preventive measures. Implications. Communication strategies emphasizing validated preventive practices and educating about the risks of consuming medicinal plants should be tailored to the predominant characteristics of the consumer. Determine the factors associated with the consumption of medicinal plants as a preventive measure against COVID-19 in the Peruvian population.</p><p><strong>Materials and methods.: </strong>A population over 18 years of age, living in Peru and without a history of COVID-19 disease, was evaluated. The factors associated with the consumption of medicinal plants were evaluated using a Poisson regression model with robust variances.</p><p><strong>Results.: </strong>Of the 3231 participants included, 84.6% were young adults (18-29 years old), 62.7% were women, and 59.7% consumed a medicinal plant to prevent COVID-19 infection. The factors associated with the consumption of medicinal plants to prevent COVID-19 infection were residing in the Peruvian highlands, having had a family member diagnosed with COVID-19, having had a family member die from COVID-19, considering their family to be at increased risk of infection, having used medications or chlorine dioxide to prevent COVID-19, having medical information as the main source of information about COVID-19, thinking that medicinal plants are effective in preventing COVID-19 disease, or not being informed about their effectiveness.</p><p><strong>Conclusion.: </strong>Sixty percent of the participants reported having consumed a medicinal plant to prevent COVID-19. Authorities must apply communication strategies about the implications of consuming medicinal plants, prioritizing population groups with higher consumption patterns.</p>\",\"PeriodicalId\":53651,\"journal\":{\"name\":\"Revista Peruana de Medicina de Experimental y Salud Publica\",\"volume\":\"41 1\",\"pages\":\"37-45\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11149759/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Peruana de Medicina de Experimental y Salud Publica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17843/rpmesp.2024.411.13265\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Peruana de Medicina de Experimental y Salud Publica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17843/rpmesp.2024.411.13265","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目标研究动机。没有研究明确建议使用药用植物来治疗 COVID-19 症状,滥用药用植物可能会带来健康风险。主要发现。60%的参与者食用药用植物来预防 COVID-19。尤其是那些生活在秘鲁高原地区的人以及有家庭成员被诊断出感染 COVID-19 或已故的人,他们认为感染的风险更高,因此使用药物或二氧化氯作为预防措施。影响。应根据消费者的主要特征制定宣传策略,强调有效的预防措施并教育人们食用药用植物的风险。确定秘鲁人食用药用植物作为预防 COVID-19 的措施的相关因素:对居住在秘鲁且无 COVID-19 疾病史的 18 岁以上人群进行了评估。采用稳健方差泊松回归模型对与药用植物消费相关的因素进行了评估:在 3231 名参与者中,84.6% 为青壮年(18-29 岁),62.7% 为女性,59.7% 食用药用植物以预防 COVID-19 感染。与食用药用植物预防 COVID-19 感染相关的因素包括:居住在秘鲁高原地区、家庭成员曾被诊断患有 COVID-19、家庭成员曾死于 COVID-19、认为家人感染 COVID-19 的风险增加、曾使用药物或二氧化氯预防 COVID-19、医疗信息是 COVID-19 的主要信息来源、认为药用植物能有效预防 COVID-19 疾病或不了解药用植物的功效:60%的参与者表示曾食用药用植物来预防 COVID-19。有关当局必须采取宣传策略,让人们了解食用药用植物的意义,并优先考虑食用药用植物较多的人群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Factors associated with the consumption of medicinal plants for the prevention of COVID-19 in peruvian population: a cross-sectional study.

Objectives.: Motivation for the study. No study conclusively recommends the use of medicinal plants to treat COVID-19 symptoms, and their indiscriminate use may present health risks. Main findings. Sixty percent of participants consumed medicinal plants to prevent COVID-19. This was particularly true for those living in the Peruvian highlands and individuals with family members diagnosed or deceased from COVID-19, who perceive a higher risk of infection and use medications or chlorine dioxide as preventive measures. Implications. Communication strategies emphasizing validated preventive practices and educating about the risks of consuming medicinal plants should be tailored to the predominant characteristics of the consumer. Determine the factors associated with the consumption of medicinal plants as a preventive measure against COVID-19 in the Peruvian population.

Materials and methods.: A population over 18 years of age, living in Peru and without a history of COVID-19 disease, was evaluated. The factors associated with the consumption of medicinal plants were evaluated using a Poisson regression model with robust variances.

Results.: Of the 3231 participants included, 84.6% were young adults (18-29 years old), 62.7% were women, and 59.7% consumed a medicinal plant to prevent COVID-19 infection. The factors associated with the consumption of medicinal plants to prevent COVID-19 infection were residing in the Peruvian highlands, having had a family member diagnosed with COVID-19, having had a family member die from COVID-19, considering their family to be at increased risk of infection, having used medications or chlorine dioxide to prevent COVID-19, having medical information as the main source of information about COVID-19, thinking that medicinal plants are effective in preventing COVID-19 disease, or not being informed about their effectiveness.

Conclusion.: Sixty percent of the participants reported having consumed a medicinal plant to prevent COVID-19. Authorities must apply communication strategies about the implications of consuming medicinal plants, prioritizing population groups with higher consumption patterns.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Revista Peruana de Medicina de Experimental y Salud Publica
Revista Peruana de Medicina de Experimental y Salud Publica Medicine-Public Health, Environmental and Occupational Health
CiteScore
3.00
自引率
0.00%
发文量
57
审稿时长
12 weeks
期刊介绍: La Revista Peruana de Medicina Experimental y Salud Pública (RPMESP) es el órgano oficial de difusión científica del Instituto Nacional de Salud (INS) del Perú. Es una publicación arbitrada por pares, de periodicidad trimestral, de ámbito y difusión mundial, indizada en MEDLINE/Index Medicos, SCOPUS, EMBASE, SciELO Salud Pública y otras bases de datos internacionales. La RPMESP es distribuida en su versión impresa y electrónica, con acceso gratuito a texto completo. La RPMESP publica artículos referidos a temas del ámbito biomédico y de salud pública, resaltando aportes prácticos, que contribuyan a mejorar la situación de salud del país y de la región. Propicia el intercambio de la experiencia científica en salud entre instituciones y personas dedicadas a la investigación dentro y fuera del Perú a fin de promover el avance y la aplicación de la investigación en salud.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信